-
Je něco špatně v tomto záznamu ?
Safety of Early Carotid Endarterectomy after Intravenous Thrombolysis in Acute Ischemic Stroke
I. Gunka, D. Krajickova, M. Lesko, O. Renc, J. Raupach, S. Jiska, M. Lojik, V. Chovanec, R. Maly,
Jazyk angličtina Země Nizozemsko
Typ dokumentu srovnávací studie, časopisecké články
- MeSH
- čas zasáhnout při rozvinutí nemoci * MeSH
- časové faktory MeSH
- cévní mozková příhoda diagnóza farmakoterapie etiologie mortalita MeSH
- fibrinolytika aplikace a dávkování škodlivé účinky MeSH
- intravenózní podání MeSH
- ischemie mozku diagnóza farmakoterapie etiologie mortalita MeSH
- karotická endarterektomie * škodlivé účinky mortalita MeSH
- lidé středního věku MeSH
- lidé MeSH
- nemoci arterie carotis komplikace diagnostické zobrazování mortalita chirurgie MeSH
- registrace MeSH
- retrospektivní studie MeSH
- rizikové faktory MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- trombolytická terapie * škodlivé účinky MeSH
- výsledek terapie MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- srovnávací studie MeSH
BACKGROUND: The timing of carotid endarterectomy (CEA) after intravenous thrombolysis (IVT) is still a controversial issue. The aim of this study was to assess the safety of early carotid interventions in patients treated with thrombolysis for acute ischemic stroke. METHODS: A retrospective analysis was performed using prospectively collected data from consecutive patients who underwent CEA for symptomatic internal carotid artery stenosis within 14 days after the index neurological event during the period from January 2013 to July 2016. Patients who had undergone IVT before CEA were identified. The primary outcome measures were any stroke and death rate at 30 days, symptomatic intracerebral hemorrhage and surgical site bleeding requiring intervention. RESULTS: A total of 93 patients were included for the final analysis. Among these, 13 (14.0%) patients had undergone IVT before CEA while 80 (86.0%) patients had CEA only. The median time interval between IVT and CEA was 2 days (range: 0-13). A subgroup of 6 patients underwent CEA within 24 hours of administration of IVT. The 30-day combined stroke and death rate was 7.7% (1 of 13) among patients undergoing IVT before CEA and 5.0% (4 of 80) among those undergoing CEA only (P = 0.690). In the IVT group, there were no cerebral hemorrhages or significant surgical site bleeding events requiring reintervention. CONCLUSIONS: Our experience indicates that CEA performed early after IVT for acute ischemic stroke, aiming not only to reduce the risk of stroke recurrence but also to achieve neurological improvement by reperfusion of the ischemic penumbra, may be safe and can lead to favorable outcomes.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18033908
- 003
- CZ-PrNML
- 005
- 20181017151405.0
- 007
- ta
- 008
- 181008s2017 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.avsg.2017.03.195 $2 doi
- 035 __
- $a (PubMed)28479465
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Gunka, Igor $u Department of Surgery, Faculty of Medicine in Hradec Králové, University Hospital Hradec Kralové, Charles University, Hradec Kralove, Czech Republic. Electronic address: gunka@email.cz.
- 245 10
- $a Safety of Early Carotid Endarterectomy after Intravenous Thrombolysis in Acute Ischemic Stroke / $c I. Gunka, D. Krajickova, M. Lesko, O. Renc, J. Raupach, S. Jiska, M. Lojik, V. Chovanec, R. Maly,
- 520 9_
- $a BACKGROUND: The timing of carotid endarterectomy (CEA) after intravenous thrombolysis (IVT) is still a controversial issue. The aim of this study was to assess the safety of early carotid interventions in patients treated with thrombolysis for acute ischemic stroke. METHODS: A retrospective analysis was performed using prospectively collected data from consecutive patients who underwent CEA for symptomatic internal carotid artery stenosis within 14 days after the index neurological event during the period from January 2013 to July 2016. Patients who had undergone IVT before CEA were identified. The primary outcome measures were any stroke and death rate at 30 days, symptomatic intracerebral hemorrhage and surgical site bleeding requiring intervention. RESULTS: A total of 93 patients were included for the final analysis. Among these, 13 (14.0%) patients had undergone IVT before CEA while 80 (86.0%) patients had CEA only. The median time interval between IVT and CEA was 2 days (range: 0-13). A subgroup of 6 patients underwent CEA within 24 hours of administration of IVT. The 30-day combined stroke and death rate was 7.7% (1 of 13) among patients undergoing IVT before CEA and 5.0% (4 of 80) among those undergoing CEA only (P = 0.690). In the IVT group, there were no cerebral hemorrhages or significant surgical site bleeding events requiring reintervention. CONCLUSIONS: Our experience indicates that CEA performed early after IVT for acute ischemic stroke, aiming not only to reduce the risk of stroke recurrence but also to achieve neurological improvement by reperfusion of the ischemic penumbra, may be safe and can lead to favorable outcomes.
- 650 _2
- $a intravenózní podání $7 D061605
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a ischemie mozku $x diagnóza $x farmakoterapie $x etiologie $x mortalita $7 D002545
- 650 _2
- $a nemoci arterie carotis $x komplikace $x diagnostické zobrazování $x mortalita $x chirurgie $7 D002340
- 650 12
- $a karotická endarterektomie $x škodlivé účinky $x mortalita $7 D016894
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a fibrinolytika $x aplikace a dávkování $x škodlivé účinky $7 D005343
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a registrace $7 D012042
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a cévní mozková příhoda $x diagnóza $x farmakoterapie $x etiologie $x mortalita $7 D020521
- 650 12
- $a trombolytická terapie $x škodlivé účinky $7 D015912
- 650 _2
- $a časové faktory $7 D013997
- 650 12
- $a čas zasáhnout při rozvinutí nemoci $7 D061665
- 650 _2
- $a výsledek terapie $7 D016896
- 655 _2
- $a srovnávací studie $7 D003160
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Krajickova, Dagmar $u Department of Neurology, Faculty of Medicine in Hradec Králové, University Hospital Hradec Kralové, Charles University, Hradec Kralove, Czech Republic.
- 700 1_
- $a Lesko, Michal $u Department of Surgery, Faculty of Medicine in Hradec Králové, University Hospital Hradec Kralové, Charles University, Hradec Kralove, Czech Republic.
- 700 1_
- $a Renc, Ondrej $u Department of Radiology, Faculty of Medicine in Hradec Králové, University Hospital Hradec Kralové, Charles University, Hradec Kralove, Czech Republic.
- 700 1_
- $a Raupach, Jan $u Department of Radiology, Faculty of Medicine in Hradec Králové, University Hospital Hradec Kralové, Charles University, Hradec Kralove, Czech Republic.
- 700 1_
- $a Jiska, Stanislav $u Department of Surgery, Faculty of Medicine in Hradec Králové, University Hospital Hradec Kralové, Charles University, Hradec Kralove, Czech Republic.
- 700 1_
- $a Lojik, Miroslav $u Department of Radiology, Faculty of Medicine in Hradec Králové, University Hospital Hradec Kralové, Charles University, Hradec Kralove, Czech Republic.
- 700 1_
- $a Chovanec, Vendelin $u Department of Radiology, Faculty of Medicine in Hradec Králové, University Hospital Hradec Kralové, Charles University, Hradec Kralove, Czech Republic.
- 700 1_
- $a Maly, Radovan $u First Department of Internal Medicine-Cardioangiology, Faculty of Medicine in Hradec Králové, University Hospital Hradec Kralové, Charles University, Hradec Kralove, Czech Republic.
- 773 0_
- $w MED00005646 $t Annals of vascular surgery $x 1615-5947 $g Roč. 44, č. - (2017), s. 353-360
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28479465 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20181008 $b ABA008
- 991 __
- $a 20181017151904 $b ABA008
- 999 __
- $a ok $b bmc $g 1339651 $s 1030902
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 44 $c - $d 353-360 $e 20170504 $i 1615-5947 $m Annals of vascular surgery $n Ann Vasc Surg $x MED00005646
- LZP __
- $a Pubmed-20181008